Free Oncologists quickly react to label changes for immunotherapies, a study by Penn, Flatiron shows September 27, 2019Vol.45 No.36By Matthew Bin Han Ong
Free E-cigarette use rises in young adults as combustible cigarette use declines September 27, 2019Vol.45 No.36By Alexandria Carolan
Conversation with The Cancer LetterFree In a globe-spanning action, FDA and regulators in Australia, Canada jointly approve endometrial carcinoma therapy September 20, 2019Vol.45 No.35By Paul Goldberg
Challenges to leveraging real-world evidence for FDA approval September 20, 2019Vol.45 No.35By Ash Malik
Conversation with The Cancer Letter Fred Hutch’s Gilliland to step down in 2020 as part of what he sees as generational change September 20, 2019Vol.45 No.35By Paul Goldberg
Senate committee recommends $3 billion increase for NIH funding September 20, 2019Vol.45 No.35By Alexandria Carolan
FDA begins technology overhaul in preparation for tsunami of data and real-world evidence September 20, 2019Vol.45 No.35By Matthew Bin Han Ong
Guest Editorial Herceptin: What it took to make it happen September 20, 2019Vol.45 No.35By Robert Bazell
Conversation with The Cancer LetterFree Michigan’s Philip Stella receives NCORP 2019 Harry Hynes Award September 13, 2019Vol.45 No.34By Paul Goldberg
The 2019 Lasker Awards go to: Max D. Cooper, Jacques Miller, Michael Shepard, Dennis J. Slamon, Axel Ullrich, and Gavi, the Vaccine Alliance September 13, 2019Vol.45 No.34
